tbuckley/cabot-search huggingface dataset:
Layered Effusion
Authors: C. Scott Williams
Journal: Annals of Internal Medicine (2016)

Ad Libitum15 November 2016Layered EffusionC. Scott Williams, MDC. Scott Williams, MDFrom Huntsville Clinic Family Practice, Huntsville, Alabama.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M16-1452 Audio Reading - “Layered Effusion” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Layered Effusion," by C.S. Williams. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The space should be theoreticalBetween flesh of my fleshAnd bone of my bone.But this growing divideMakes everything difficult:Speaking, sleeping, breathing is labor.This intrusive fluid retracts from embrace.It muffles phonation and pains for attention.It aches its persistence with contentBoth inflammatory and malignant.I can only await prognosis in silence…Might this separation be expunged,Or is intervention futile to preventAn inevitable recurrence?How long shall we live and suffer…A year, six months, less?There is much in commonBetween dissolution and effusion. Author, Article, and Disclosure InformationAffiliations: From Huntsville Clinic Family Practice, Huntsville, Alabama.Current Author Address: C. Scott Williams, MD, Huntsville Clinic Family Practice, 420 Lowell Drive SE, Suite 107, Huntsville, AL 35801; e-mail, [email protected]net. PreviousarticleNextarticle Advertisement Audio Reading - “Layered Effusion” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Layered Effusion," by C.S. Williams. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ FiguresReferencesRelatedDetails Metrics 15 November 2016Volume 165, Issue 10Page: 728KeywordsBoneBreathingPain ePublished: 15 November 2016 Issue Published: 15 November 2016 Copyright & PermissionsCopyright © 2016 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Aspirin use and cardiovascular disease in women
Authors: R. B. D'Agostino
Journal: JAMA (1992)

<h3>To the Editor.</h3> —In their recent article, Manson et al<sup>1</sup>reported a reduced risk of myocardial infarction (MI) in women who took one through six aspirin per week. An analysis of data from the Framingham Heart Study suggests a similar effect in older men and women for cardiovascular disease (CVD) and cerebrovascular disease, including transient ischemic attacks. <h3>Study.</h3> —At biennial examination 17 in 1981 to 1983, the examining physician recorded the number of aspirin taken per week. Of the 508 men and 917 women aged 63 through 94 years who were free of CVD and who were followed up through examination 19, there were 17% who reported taking one through six aspirin per week, 12% reported taking seven or more aspirin per week, and 71% reported taking no aspirin. Information on the indications for aspirin use was not collected. By the end of examination 19 (4 years
Immunology Research
Authors: A. Wu, J. Wei, L.-Y. Kong, Y. Wang, W. Priebe, R. Sawaya, A. B. Heimberger, J. Wei, A. Wu, L.-Y. Kong, Y. Wang, W. Priebe, A. Heimberger, L.-Y. Kong, T. Doucette, J. Wei, W. Priebe, R. Sawaya, J. Yang, G. Rao, A. Heimberger, S. Shimato, L. M. Meier, M. Castelli, P. Canoll, M. Asslaber, J. N. Bruce, D. E. Anderson, R. C. Anderson, E. W. Mahlum, R. B. Jenkins, G. Kohanbash, A. H. Mintz, K. McKaveney, H. A. McDonald, J. R. Ohlfest, H. Okada, M. Fujita, L. Zhang, W. Liu, D. Alizadeh, D. Zhao, O. Farrukh, B. Badie, B. Raychaudhuri, S. Pellegatta, G. Cantini, F. Pisati, L. Cuppini, G. Finocchiaro, E. Albesiano, J. E. Han, A. See, C. Jackson, M. Lim, K. Nag, J. White, T. Sippel, M. Klaassen, V. Tsvankin, A. Waziri, S. Mittal, I. M. Zitron, W. J. Kupsky, B. Alkonyi, S. Sood, C. Juhasz, I. M. Zitron, C. Juhasz, S. Mittal
Journal: Neuro-Oncology (2010)
Disappointed Dr Mudd vows to fight on
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Psychogenic Factors in Bronchial Asthma
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ergebnisse der medizinischen Strahlenforschung (Röntgendiagnostik, Röntgen-, Radium- und Lichttherapie).
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Elast q - 2D shear wave liver elastography correlates well with vibration controlled transcient elastography in patients with different etiologies of chronic liver disease
Authors: David JM Bauer, Annalisa De Silvestri, Dr. Laura Maiocchi, Ruxandra Mare, Ioan Sporea, Theresa Bucsics, Giovanna Ferraioli, Thomas Reiberger
Journal: Journal of Hepatology (2020)
Units of Measure Error
Authors: Paul Mills, John Fagan
Journal: JAMA (2018)

Christopher D. Gardner, PhD; John F. Trepanowski, PhD; Liana C. Del Gobbo, PhD; Michelle E. Hauser, MD; Joseph Rigdon, PhD; John P. A. Ioannidis, MD, DSc; Manisha Desai, PhD; Abby C. King, PhD
Faraway Empress
Authors: Jenna Thomason
Journal: Annals of Internal Medicine (2014)

Ad Libitum21 October 2014Faraway EmpressJenna Thomason, MD, MPHJenna Thomason, MD, MPHFrom Seattle, Washington.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-1695 Audio Reading - “Faraway Empress” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Faraway Empress," by J. Thomason. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail You are absolutely stunningcheeks pink, lips red, skin honey-browndecorated in silver and goldhair braided around your head like a crownI babble through an explicatoroverseen by all their frightened eyesverboten from disclosingwhat darkness lurks insideYour silence is hauntingnothing disrupts your downward icteric stareyour abdication came before we metyour throne reduced to an exam room chairThe air is thick with fear, pain, and self-restraintrendering it difficult for me to inquireI wish I could have known youbefore I met you as you arewith glowing ... Author, Article, and Disclosure InformationAffiliations: From Seattle, Washington.Current Author Address: Jenna Thomason, MD, MPH; e-mail, [email protected]com. PreviousarticleNextarticle Advertisement Audio Reading - “Faraway Empress” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Faraway Empress," by J. Thomason. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ FiguresReferencesRelatedDetails Metrics 21 October 2014Volume 161, Issue 8Page: 606KeywordsFear ePublished: 21 October 2014 Issue Published: 21 October 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
Authors: John W. Funder
Journal: Endocrine Reviews (2010)

Although aldosterone was not isolated and chemically characterized until 1953, the mineralocorticoid action of certain steroids, notably deoxycorticosterone (DOC), had been recognized decades earlier. From 1953 until 1990 saw the establishment of the basic biology and clinical (patho)physiology of aldosterone as an epithelial sodium retaining hormone: its biosynthesis in the adrenal glomerulosa; control of its secretion by ACTH, angiotensin II, and plasma [K+]; its action via intracellular mineralocorticoid receptors to promote DNA-directed; RNA-mediated synthesis of proteins responsible for its epithelial effects; and the syndrome of primary aldosteronism, in which secretion of the hormone is relatively autonomous of its normal stimuli. The past 2 decades have been a major extension of our understanding of the pathophysiology of aldosterone and the complexities of mineralocorticoid receptor signaling in particular. The review concludes with a brief consideration of recent findings re hormone and receptor, agonists, and antagonists. In 1990 it might reasonably have been argued that we had the overarching framework for understanding the roles of aldosterone and mineralocorticoid receptors, with only the details to be filled in. Two decades later we still do not know the boundaries, and for every answer, two questions are springing up: truly the more we learn, the less we know.
New century of achievement awaits unique National Institutes of Health
Authors: P. Gunby
Journal: JAMA (1984)

In a world full of initials and acronyms, most physicians and other medical scientists in the United States are aware that NIH stands for National Institutes of Health. But what the existence of the NIH means for the practice of medicine is another story, one that—at least in part—the MEDICAL NEWS section of this issue seeks to tell. The NIH employs nearly 15,000 persons, almost 10% of whom are physicians, and most of whom work on or near its approximately 125-hectare (slightly more than 306-acre) campus in the Washington, DC, suburb of Bethesda, Md. There are 60 buildings on the main campus. Here, as well as in other facilities in the locality and at Research Triangle Park, NC, where the National Institute of Environmental Health Sciences is located, NIH investigators, staff, and advisors concentrate on research and clinical problems. In addition to intramural research at the NIH, more than 19,000
&lt;TITLE&gt;Spina Bifida&lt;/TITLE&gt;
Journal: JAMA (2001)

a public service of JAMA.The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis.For specific information concerning your personal medical condition, JAMA and the AMA suggest that you consult your physician.This page may be reproduced noncommercially by physicians and other health care professionals to share with patients.Any other reproduction is subject to AMA approval.
Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome
Authors: B. R. Saltzman
Journal: JAMA (1986)

THE ACQUIRED immunodeficiency syndrome (AIDS) is characterized by a defect in cellular immunity and the occurrence of opportunistic infections or unusual malignant neoplasms. The most commonly reported bacterial infection suggestive of a defect in cellular immunity, which meets the Centers for Disease Control (Atlanta) case definition for AIDS, is disseminated<i>Mycobacterium avium-intracellulare</i>infection.<sup>1</sup>Disseminated infection due to<i>Mycobacterium tuberculosis</i>has also been reported in AIDS.<sup>2</sup>Bacteremia is common in disseminated<i>M avium-intracellulare</i>infection in patients with AIDS.<sup>3</sup>In contrast, bacteremia in disseminated<i>M tuberculosis</i>is rare<sup>4-6</sup>and has not been reported previously in patients with AIDS, to our knowledge. We recently diagnosed disseminated infection due to<i>M tuberculosis</i>, in which bacteremia also occurred, in an intravenous drug abuser with AIDS. <h3>Report of a Case</h3> A 35-year-old man with a three- to five-year history of intravenous heroin and cocaine abuse developed anorexia and weight loss in November
Gemtuzumab ozogamicin (GO)-associated veno-occlusive disease (VOD): An analysis of adverse drug reaction (ADR) reports in the clinical trials, clinical practice, and in the medical literature
Authors: S. A. Klinge, R. Chacko, C. L. Bennett, S. Luminari, E. A. Lyons, S. Trifilio, J. McKoy, P. R. Yarnold, D. W. Raisch, M. S. Tallman
Journal: Journal of Clinical Oncology (2004)

6616 Background: The incidence of GO-associated VOD and predisposing factors are uncertain. Barriers to understanding this toxicity are under- and incomplete ADR reporting. This concern is especially important for drugs such as GO, which receive accelerated FDA approval. Methods: We evaluated the completeness of GO-associated VOD ADR cases reported to the in the context of clinical trials (n=39) and non-clinical trial settings (n= 54), and reviewed incidence rates and predisposing factors reported in the medical literature. Results: clinical trial cases contained more information on abdominal examination findings (90% vs 59%), GO dose (92% vs 63%), GO schedule (92% vs 63%), VOD onset date (85% vs 51%), hepatic transaminases levels (72% vs 39%) and bilirubin (82% vs 57%) (p's<0.05). ADR reports indicated that GO-associated VOD was characterized by: elevated hepatic enzymes (82%), bilirubin (88%) and weight gain, ascites, or painful hepatomegaly (88%) occurring at a median of 10 days after GO administration (IQR 7.5–20). The medical literature was reviewed for incidence rates when GO was administered in both FDA-approved and "off-label" regimens, such as with hematopoietic stem cell transplantation (HSCT): Conclusions: 1) ADR reporting is more complete in the clinical trial versus the non-clinical trial setting; 2) VOD is a serious ADR that occurs at low rates when GO mono-therapy is used at the FDA approved dose and schedule and at higher rates when GO is administered at non-FDA approved doses or schedules, concurrently with other chemotherapeutic agents or when allogeneic HSCT is performed close to the time of GO administration; and 3) for cancer drugs such as GO which receive accelerated approval from the FDA, consideration should be given to mandating prospective post-marketing safety registries. No significant financial relationships to disclose.
Calculation Adjustment in Related Article
Authors: Eli Cahan, Amanda Chawla, Kevin Shea, Cassandra Thiel, Leora Horwitz
Journal: JAMA (2020)

In Reply Mr Cahan and colleagues comment on our Viewpoint 1 on the importance of supply optimization in improving the value of health care delivery.We agree with the authors that reducing variability in surgical utilization can be accomplished through consolidating device vendors and integrating purchasing decisions in a way that does not inappropriately drive practice patterns.We only add a caveat that too much consolidation, for example to a single vendor, can increase risk of supply shortages and reduce the opportunity for effective price negotiations.There are many ways to increase value in health care by focusing on resource use and supply waste.Translational research that identifies and tests best practices for supply optimization in a variety of medical settings would enable more facilities to take advantage of this potential avenue for improvement.
Instructions for Authors
Journal: JAMA (1985)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Practice
Authors: Ted McMahon
Journal: JAMA (2013)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Can forensic medicine and organ donation coexist for the public good?
Authors: R. Voelker
Journal: JAMA (1994)

IS GIVING 100% too much to ask? Medical examiners in some parts of the country say it may be, particularly if organ procurement organizations are doing the asking. Relationships between medical examiners and procurement agencies have been laced with tension for years. But the stress may be mounting. Some specialists in forensic medicine say procurement agency approaches have become increasingly aggressive. In a handful of states, they add, laws allow organ harvesting to supersede death investigations, potentially jeopardizing evidence in criminal cases. "Some [procurement organizations] are almost zealous," says Thomas Hegert, MD, the organ and tissue committee chair of the National Association of Medical Examiners (NAME). "They want us to give 100% of those cases for which we have received consent for organ procurement." Procurement agencies dispute that characterization. "There is a lot of misunderstanding," says Teresa Shafer, RN, president of the North American Transplant Coordinators Organization (NATCO). "We're looking
Forensic Psychiatry
Authors: George E. Hall
Journal: JAMA (1966)

In 1952, after 25 years in which no particularly noteworthy contributions about the psychiatrist and the law were published, two texts on the subject appeared. One of these was the first edition of this book. AJournalreview of the book at that time noted, "An attempt is made to establish a bridge of understandable communication between medicine and the law." This attempt has been largely successful, and the book has aided many psychiatrists through the years. This second edition expands upon the helpful material of the first and adds some new features demanded by subsequent legal developments. One completely new chapter discusses the psychiatrist and the laws relating to narcotic addiction and presents the legal problems which the physician faces in treating addicts, as well as the background of court decisions which have influenced doctors to stay away from attempting to treat addicts. The contrasting views between medicine and